Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Revolution Medicines, Inc. - Common Stock (NQ:RVMD)

78.33 -0.69 (-0.87%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,279,311
Open 78.44
Bid (Size) 76.30 (100)
Ask (Size) 78.69 (200)
Prev. Close 79.02
Today's Range 76.28 - 78.94
52wk Range 29.17 - 81.97
Shares Outstanding 106,313,250
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
The Great Rotation: Small Caps Lead the Charge as 2026 Trading Opens
As the opening bells of 2026 ring across Wall Street, a definitive shift in market leadership is unfolding. In the first trading sessions of the new year, the Russell 2000 index, a benchmark for... 
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
Is Cidara Therapeutics a Buy After HighVista Strategies Initiated a Position in the Stock? ↗
Is Cidara Therapeutics a Buy After HighVista Strategies Initiated a Position in the Stock? 
Via The Motley Fool
Topics Regulatory Compliance

Performance

YTD
-0.9%
-0.9%
1 Month
-2.2%
-2.2%
3 Month
+68.2%
+68.2%
6 Month
+113.6%
+113.6%
1 Year
+78.7%
+78.7%

More News

Read More
News headline image
The Small-Cap Renaissance: Why 2026 is the Year of the Russell 2000 and XSU
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
Earnings Scheduled For November 5, 2025 ↗
Via Benzinga
News headline image
Earnings Scheduled For August 6, 2025 ↗
Via Benzinga
News headline image
Up Nearly 400% This Year, Can Oklo Stock Still Rise Higher? ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Maplebear, Tower Semiconductor, And Eli Lilly Are Among the Top 10 Large-Cap Gainers Last Week (Nov. 10-Nov. 14): Are the Others in Your Portfolio? ↗
Via Benzinga
News headline image
Revolution Medicines (RVMD) Earnings Transcript ↗
Via The Motley Fool
News headline image
Tango Therapeutics Touts Encouraging Data From Early-Stage Cancer Trial, Raises Capital To Fund Advancement ↗
Via Benzinga
News headline image
Stocks Rebound, Eli Lilly Jumps To 14-Month Highs: What's Moving Markets Wednesday? ↗
Via Benzinga
Topics Economy
News headline image
Revolution Medicines, Disc Medicine, American Express And Other Big Stocks Moving Higher On Friday ↗
Via Benzinga
News headline image
The FDA Just Granted Its Speediest Review Ever. Disc Medicine, Others Fly. ↗
Via Investor's Business Daily
News headline image
FDA Unveils First Experimental Drugs Under Fast-Track Voucher Plan To Cut Drug Review Times ↗
Via Benzinga
News headline image
'No Need To Sell' Martin Marietta Materials, Cramer Says: 'It's Just A Great Long-Term Hold' ↗
Via Benzinga
News headline image
Revolution Medicines, Disc Medicine, Regeneron Stocks Jump After-Hours As FDA Fast-Tracks 9 Drugs Under New Review Program ↗
Via Stocktwits
News headline image
Analysts Raise Price Targets Following Strong Data From Revolution Medicines' Pancreatic Cancer Drug ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Via Benzinga
News headline image
Aon To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Via Benzinga
News headline image
This Parker-Hannifin Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday ↗
Via Benzinga
News headline image
Revolution Medicines Inc (NASDAQ:RVMD) Reports Q2 2025 Earnings Miss, Shares Drop 4.5% After-Hours ↗
Via Chartmill
Topics Earnings
News headline image
This GitLab Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗
Via Benzinga
News headline image
Revolution Medicines and Summit Therapeutics Enter Into Clinical Collaboration to Evaluate Combinations of Three RAS(ON) Inhibitors With Ivonescimab in RAS Mutant Tumors
From Summit Therapeutics Inc.
Via Business Wire
News headline image
Revolution Medicines To Advance Lead Cancer Drug With $2 Billion In Funds ↗
Via Benzinga
News headline image
Revolution Medicines To Get Up To $2B For Development Of Cancer Drug From Royalty Pharma ↗
Via Stocktwits

Frequently Asked Questions

Is Revolution Medicines, Inc. - Common Stock publicly traded?
Yes, Revolution Medicines, Inc. - Common Stock is publicly traded.
What exchange does Revolution Medicines, Inc. - Common Stock trade on?
Revolution Medicines, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Revolution Medicines, Inc. - Common Stock?
The ticker symbol for Revolution Medicines, Inc. - Common Stock is RVMD on the Nasdaq Stock Market
What is the current price of Revolution Medicines, Inc. - Common Stock?
The current price of Revolution Medicines, Inc. - Common Stock is 78.33
When was Revolution Medicines, Inc. - Common Stock last traded?
The last trade of Revolution Medicines, Inc. - Common Stock was at 01/05/26 04:00 PM ET
What is the market capitalization of Revolution Medicines, Inc. - Common Stock?
The market capitalization of Revolution Medicines, Inc. - Common Stock is 8.33B
How many shares of Revolution Medicines, Inc. - Common Stock are outstanding?
Revolution Medicines, Inc. - Common Stock has 8B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.